0001140361-18-003088.txt : 20180124
0001140361-18-003088.hdr.sgml : 20180124
20180124170409
ACCESSION NUMBER: 0001140361-18-003088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180122
FILED AS OF DATE: 20180124
DATE AS OF CHANGE: 20180124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Anthony
CENTRAL INDEX KEY: 0001606030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 18545930
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc1.xml
FORM 4
X0306
4
2018-01-22
0
0000730272
REPLIGEN CORP
RGEN
0001606030
Hunt Anthony
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
Chief Executive Officer
Common Stock
2018-01-22
4
S
0
8970
35.947
D
83613
D
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 17, 2017.
$35.947 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.58 to $36.28, inclusive. The reporting person undertakes to
provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares
sold at each separate price within the range.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2018-01-24